ReviewThe Journal of reproduction and development2026
The current status of artificial reproductive technologies in sheep.
Review in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial reproductive technologies (ARTs) are central to genetic improvement strategies in livestock, yet adoption remains inconsistent across species. In sheep, uptake has lagged behind that of cattle due to species‑specific reproductive biology, variable oocyte and embryo competence following use of exogenous hormones, economic feasibility and inconsistent success rates. This review synthesises the principles, methodological development, and contemporary performance of semen collection and cryopreservation, artificial insemination (AI), multiple ovulation embryo transfer (MOET), and in vitro fertilization and embryo production (IVF) in sheep, and integrates insights from a global survey of commercial sheep artificial breeding providers (68% response rate; N = 41) on the current size and scale of the industry. It also collates data on optimisation studies working to improve success rates in these technologies. Survey data reveal marked heterogeneity in semen processing practices, cryopreservation method, extender use, insemination dose preparation, and oestrus synchronisation protocols. Laparoscopic intrauterine AI remains the predominant technique, yielding a global weighted pregnancy rate of 71%, despite substantial site, sire, and operator‑dependent variation. MOET is widely implemented, producing an average of 6-8 transferable embryos per donor, with fresh embryo transfer outperforming frozen-thawed embryos across global regions. In contrast, IVF in sheep continues to face technical and commercial constraints related to oocyte recovery, in vitro maturation, and blastocyst development. Collectively, this review highlights critical opportunities for standardised semen assessment, optimised hormone protocols, advanced predictive analytics, and targeted commercialisation of ovine IVP systems to enhance reproducibility, efficiency, and genetic gain within the global sheep artificial breeding industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.